Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹50.00 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹50.00 Cr |
| Fresh Issue | ₹47.50 Cr |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹125.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | NIDAN |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | First Overseas Capital Ltd. |
| Allotment Status | |
| DRHP |
| RHP |
| Final Prospectus |
 ₹0 A/C OpeningFree MF ₹20F&O Trade ₹0Delivery 1Cr+Customers Open Free Account → |
 ₹0 A/C Opening₹0 AMC Trading Account ₹20F&O Trade ₹20Delivery FreeIPO Apply Open Free Account → |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,000 shares and in multiples thereof
Incorporated in the year 2000, Nidan Laboratories and Healthcare Limited offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. As of March 31, 2021, the company offered approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.
Nidan has come out with a unique appointment booking mobile application under the name of "NIDAN HEALTHCARE" which is supported by self-indigenous software called "Nidan Operation Management (NOM)." This unique app enables patients to book appointments for any test, from anywhere, at any time. The company has also tied up with pathology partners like Metropolis Laboratories Limited for its services.
Out of the 35 centers operating under the brand name of "Nidan Healthcare", 16 centers are under the Franchisee model where 1 center acts as a fully operated diagnostic center and 15 centers act solely as standalone collection centers. As of June 30, 2021, the company had a total of 213 employees. The company has got recognitions like the Best Diagnostic Chain of India Award 2019, in the Category of 20+ diagnostic centers by Express Healthcare.
Competitive Strengths:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment of Loans | 16.00 |
| 2 | Additional Working Capital | 26.00 |
| 3 | General Corporate Expenses | 4.40 |
| 4 | To meet the expenses of the Issue | 3.60 |
| Period Ended | 30 Jun 2021 | 31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 |
|---|---|---|---|---|
| Assets | 54.33 | 52.44 | 45.21 | 43.06 |
| Total Income | 7.85 | 21.85 | 22.19 | 20.97 |
| Profit After Tax | 1.09 | 2.30 | 0.71 | 0.22 |
| NET Worth | 14.42 | 13.33 | 11.03 | 10.31 |
| Total Borrowing | 37.09 | 36.50 | 34.35 | 32.17 |
| Amount in ₹ Crore | ||||
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Issue management fees including fees and reimbursements of Market Making fees and payment to other intermediaries such as Legal Advisors to the IPO, Registrars and other out of pocket expenses | 2.60 |
| 2 | Advertising and marketing expenses | 0.60 |
| 3 | Printing & Stationery, Distribution, Postage | 0.05 |
| 4 | Regulatory and other statutory expenses including Listing Fee | 0.35 |
Last Updated on 13-May-2026 10:31:36
